Performance of SLDB Solid Biosciences LLC | 94.9% in 12m
Compare SLDB with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Solid Biosciences LLC with its related Sector/Index XBI
Performance Duell SLDB vs XBI
| TimeFrame | SLDB | XBI |
|---|---|---|
| 1 Week | 1.78% | 1.81% |
| 1 Month | -17.8% | -0.38% |
| 3 Months | -37.5% | -0.56% |
| 6 Months | -34.8% | 15.24% |
| 12 Months | 94.9% | 44.41% |
| YTD | -8.32% | 9.23% |
| Rel. Perf. 1m | -1.93 | |
| Rel. Perf. 3m | -3.22 | |
| Rel. Perf. 6m | -6.09 | |
| Rel. Perf. 12m | 3.77 | |
| Spearman 1m | -0.74 | 0.335 |
| Spearman 3m | -0.80 | 0.092 |
Is Solid Biosciences LLC a good stock to buy?
No, based on ValueRay Analyses, Solid Biosciences LLC (NASDAQ:SLDB) is currently (November 2024)
a stock to sell. It has a ValueRay Growth Rating of -76.84 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SLDB as of November 2024 is 3.69. This means that SLDB is currently overvalued and has a potential downside of -35.6% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SLDB as of November 2024 is 3.69. This means that SLDB is currently overvalued and has a potential downside of -35.6% (Sold with Premium).
Is SLDB a buy, sell or hold?
- Strong Buy: 4
- Buy: 4
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: SLDB is performing better - Values below 0%: SLDB is underperforming
Compare SLDB with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.43% | -18.88% | -49.24% | 58.43% |
| US NASDAQ 100 | QQQ | 0.14% | -19.49% | -49.86% | 57.39% |
| US Dow Jones Industrial 30 | DIA | 2.58% | -17.50% | -45.62% | 68.05% |
| German DAX 40 | DAX | 1.67% | -14.48% | -41.75% | 66.38% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.90% | -13.84% | -44.96% | 81.47% |
| Hongkong Hang Seng | HSI | 1.22% | -13.88% | -47.60% | 85.25% |
| India NIFTY 50 | INDA | 2.63% | -11.74% | -39.49% | 69.44% |
| Brasil Bovespa | EWZ | 1.17% | -13.35% | -26.50% | 99.33% |
SLDB Solid Biosciences LLC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.03% | -20.50% | -52.74% | 53.84% |
| Consumer Discretionary | XLY | -1.26% | -17.58% | -46.36% | 67.31% |
| Consumer Staples | XLP | 3.70% | -14.51% | -42.04% | 74.71% |
| Energy | XLE | 3.75% | -18.06% | -27.64% | 90.89% |
| Financial | XLF | 1.74% | -21.78% | -51.32% | 51.22% |
| Health Care | XLV | 3.30% | -13.96% | -41.09% | 76.22% |
| Industrial | XLI | 2.74% | -17.75% | -45.19% | 58.40% |
| Materials | XLB | 2.92% | -15.98% | -40.62% | 70.46% |
| Real Estate | XLRE | 2.57% | -16.22% | -56.12% | 62.21% |
| Technology | XLK | 1.26% | -19.50% | -49.63% | 58.84% |
| Utilities | XLU | 5.47% | -15.70% | -54.45% | 62.06% |
| Aerospace & Defense | XAR | 2.85% | -18.50% | -50.48% | 62.07% |
| Biotech | XBI | -0.03% | -17.41% | -50.05% | 50.49% |
| Homebuilder | XHB | 4.20% | -10.14% | -45.18% | 41.46% |
| Retail | XRT | 2.19% | -14.87% | -38.52% | 68.23% |
Does Solid Biosciences LLC outperform its market, is SLDB a Sector Leader?
Yes, over the last 12 months Solid Biosciences LLC (SLDB) made 94.90%, while its related Sector, the SPDR S&P Biotech (XBI) made 44.41%.
Over the last 3 months SLDB made -37.51%, while XBI made -0.56%.
Yes, over the last 12 months Solid Biosciences LLC (SLDB) made 94.90%, while its related Sector, the SPDR S&P Biotech (XBI) made 44.41%.
Over the last 3 months SLDB made -37.51%, while XBI made -0.56%.
| Period | SLDB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -17.79% | -0.38% | 1.09% |
| 3 Months | -37.51% | -0.56% | 7.34% |
| 12 Months | 94.90% | 44.41% | 36.47% |